Form 8-K - Current report:
SEC Accession No. 0001213900-25-023230
Filing Date
2025-03-12
Accepted
2025-03-12 16:30:15
Documents
15
Period of Report
2025-03-07
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0233959-8k_aditxt.htm   iXBRL 8-K 36575
2 CERTIFICATE OF AMENDMENT TO CERTIFICATE OF INCORPORATION OF ADITXT, INC ea023395901ex3-1_aditxt.htm EX-3.1 6388
3 PRESS RELEASE DATED MARCH 12, 2025 ea023395901ex99-1_aditxt.htm EX-99.1 9348
  Complete submission text file 0001213900-25-023230.txt   238428

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE adtx-20250307.xsd EX-101.SCH 3009
5 XBRL LABEL FILE adtx-20250307_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE adtx-20250307_pre.xml EX-101.PRE 22355
17 EXTRACTED XBRL INSTANCE DOCUMENT ea0233959-8k_aditxt_htm.xml XML 3901
Mailing Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219
Business Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219 909-488-0844
Aditxt, Inc. (Filer) CIK: 0001726711 (see all company filings)

EIN.: 823204328 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39336 | Film No.: 25732146
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)